BioSpace News Archive

ValGenesis, Inc., a market leader in Enterprise Validation Lifecycle Management Solutions (VLMS), today announced a technology partnership with T-Systems North America in its effort to help Life Science sector’s transformation to Industrial Internet of Things (IIoT) Technology, which is becoming extremely critical in pharmaceutical and biotech manufacturing where sub-optimal environmental conditions have often lead to noncompliance.

BioTelemetry, Inc. (NASDAQ:BEAT) will release its third quarter 2019 earnings on Tuesday, November 5 at 4:00 PM Eastern Time.

Johnson & Johnson Consumer Inc. (the Company) today announced that 15 new tests from the same bottle of Johnson’s Baby Powder previously tested by the U.S. Food and Drug Administration (FDA) found no asbestos

Adaptive Biotechnologies (Nasdaq: ADPT) today announced that it will report financial results for the third quarter of 2019 after market close on Tuesday, November 12, 2019.

Synthorx, Inc. (NASDAQ: THOR), a clinical-stage biotechnology company developing optimized therapeutics for cancer and autoimmune disorders, today announced the presentation of three posters at the upcoming Society for Immunotherapy of Cancer (SITC) 34th Annual Meeting in National Harbor, MD, from November 6-10, 2019.

Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial results for the three months ended September 30, 2019.

OpGen, Inc. (NASDAQ: OPGN) announced today that the Company will report its third quarter 2019 financial results after the close of the U.S. financial markets on Wednesday, November 6, 2019.

Updates Phase 1 PROCLAIM-CX-072-001 Ipilimumab Combination Study Data

Amedisys, Inc. reported its financial results for the three and nine-month periods ended September 30, 2019.

Accuray Incorporated (NASDAQ: ARAY) today reported its financial results for the first quarter of fiscal 2020 ended September 30, 2019.